MYGN - Myriad Genetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MYGN is currently covered by 7 analysts with an average price target of $6.42. This is a potential upside of $2.14 (50%) from yesterday's end of day stock price of $4.28.

Myriad Genetics's activity chart (see below) currently has 221 price targets and 181 ratings on display. The stock rating distribution of MYGN is 83.33% HOLD and 16.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.73% with an average time for these price targets to be met of 153.89 days.

Highest price target for MYGN is $9, Lowest price target is $3, average price target is $6.42.

Most recent stock forecast was given by JOHN WILKIN from CRAIG HALLUM on 01-Oct-2026. First documented stock forecast 30-May-2013.

Currently out of the existing stock ratings of MYGN, 10 are a HOLD (83.33%), 2 are a BUY (16.67%).

Split History since 2000:

3/26/09 2 for 1

9/12/00 2 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Feb-2025

$8

$3.46 (76.21%)

$18

6 days ago
(01-Oct-2026)

0/3 (0%)

$3.46 (76.21%)

Hold Since 09-Dec-2024

$3.6

$-0.94 (-20.70%)

$6

29 days ago
(08-Sep-2026)

4/6 (66.67%)

$0.41 (12.85%)

66

Hold Since 05-Oct-2022

$3

$-1.54 (-33.92%)

1 months 20 days ago
(17-Aug-2026)

3/3 (100%)

$0.13 (4.53%)

193

Hold Since 05-May-2026

$4

$-0.54 (-11.89%)

$6

2 months 7 days ago
(30-Jul-2026)

2/2 (100%)

$1.14 (39.86%)

52

Hold Since 24-Feb-2026

$5.5

$-0.38 (-6.46%)

$6

5 months 1 days ago
(06-May-2026)

13/14 (92.86%)

$1.39 (33.82%)

124

Show more analysts

Please expand the browser size to see the chart

What is MYGN (Myriad Genetics) average time for price targets to be met?

On average it took 154 days for the stock forecasts to be reached, with an average price target met ratio of 66.73%.

Which analyst most recently updated their price target on MYGN (Myriad Genetics)?

John Wilkin

Which analyst has the most public recommendations on MYGN (Myriad Genetics)?

John Wilkin works at CRAIG HALLUM and has 3 price targets and 2 ratings on MYGN

Which analyst is the currently most bullish on MYGN (Myriad Genetics)?

Drew Jones with the highest potential upside of $47.46

Which analyst is the currently most reserved on MYGN (Myriad Genetics)?

Mason Carrico with the lowest potential downside of -$1.54
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?